A

Akebia Therapeutics (AKBA)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Akebia Therapeutics (AKBA)

Akebia Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on producing medicines for people living with kidney disease. Its lead product candidate, vadadustat, is an oral therapy in development for the treatment of anemia due t... Read more

  • 0.25
  • 0.28
  • 0.25
  • 2.93
  • -3.5%
  • 297M
  • 2.30M
  • 1.30M
  • 47M
  • 0.24
  • -90.6%
  • %

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.